{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Tazemetostat  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tazemetostat. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tazemetostat  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "tazemetostat",
    "trial_2_text": "Tazemetostat  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Tazemetostat Supplement: 60 participants will take Tazemetostat 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tazemetostat. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tazemetostat  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.37421536445617676,
      "78": 0.365275114774704,
      "189": 0.3495926260948181,
      "188": 0.3137357831001282,
      "123": 0.26506492495536804,
      "173": 0.2269386202096939,
      "20": 0.2228093296289444,
      "17": 0.21577928960323334,
      "177": 0.20521050691604614,
      "68": 0.19991618394851685,
      "37": 0.1932646781206131,
      "49": 0.1924721747636795,
      "21": 0.18869346380233765,
      "228": 0.18764112889766693,
      "9": 0.1747497022151947,
      "67": 0.16910997033119202,
      "350": 0.16301439702510834,
      "46": 0.15967866778373718,
      "14": 0.15110230445861816,
      "2": 0.1507750302553177,
      "77": 0.1494074910879135,
      "64": 0.14672613143920898,
      "193": 0.14099009335041046,
      "200": 0.13911117613315582,
      "29": 0.133794367313385,
      "79": 0.13349130749702454,
      "261": 0.1327994018793106,
      "239": 0.13148050010204315,
      "101": 0.12322352081537247,
      "179": 0.12045417726039886,
      "243": 0.12023238837718964,
      "104": 0.11735278367996216,
      "114": 0.11728838831186295,
      "72": 0.11567530035972595,
      "194": 0.11346425116062164,
      "126": 0.11162889748811722,
      "38": 0.10649485141038895,
      "341": 0.10362819582223892,
      "5": 0.10260312259197235,
      "191": 0.10086949169635773,
      "131": 0.10062013566493988,
      "27": 0.10021936148405075,
      "85": 0.09719329327344894,
      "76": 0.09671102464199066,
      "180": 0.0923985168337822,
      "30": 0.09003586322069168,
      "35": 0.08902698755264282,
      "86": 0.08825228363275528,
      "102": 0.08738179504871368,
      "396": 0.08685968071222305,
      "355": 0.08603250980377197,
      "249": 0.08340895920991898,
      "116": 0.08210941404104233,
      "151": 0.0806485041975975,
      "61": 0.07937058806419373,
      "288": 0.07737591117620468,
      "186": 0.07678040117025375,
      "139": 0.0766635611653328,
      "130": 0.07530320435762405,
      "82": 0.07500260323286057,
      "204": 0.0742250457406044,
      "147": 0.0727420374751091,
      "441": 0.07246043533086777,
      "269": 0.07179846614599228,
      "122": 0.06918729841709137,
      "144": 0.06766313314437866,
      "33": 0.06747309863567352,
      "28": 0.06637466698884964,
      "282": 0.06610473245382309,
      "466": 0.06574515253305435,
      "422": 0.0642067939043045,
      "97": 0.0637703463435173,
      "69": 0.0635221004486084,
      "253": 0.06292397528886795,
      "36": 0.06139783188700676,
      "212": 0.06099100410938263,
      "234": 0.060795191675424576,
      "18": 0.06044916436076164,
      "1": 0.0604192316532135,
      "286": 0.060239434242248535,
      "276": 0.06004708632826805,
      "356": 0.05765151232481003,
      "100": 0.057039160281419754,
      "297": 0.056834422051906586,
      "96": 0.05656188353896141,
      "454": 0.05597817525267601,
      "221": 0.05530937761068344,
      "361": 0.05521675944328308,
      "154": 0.054895639419555664,
      "136": 0.05399729311466217,
      "164": 0.05360225588083267,
      "142": 0.052740052342414856,
      "132": 0.052551593631505966,
      "75": 0.05209662765264511,
      "92": 0.051745735108852386,
      "256": 0.051708560436964035,
      "257": 0.05033358559012413,
      "535": 0.0501839742064476,
      "382": 0.04924115538597107,
      "211": 0.04898109287023544
    },
    "trial_2_ae": {
      "87": 0.37421536445617676,
      "78": 0.365275114774704,
      "189": 0.3495926260948181,
      "188": 0.3137357831001282,
      "123": 0.26506492495536804,
      "173": 0.2269386202096939,
      "20": 0.2228093296289444,
      "17": 0.21577928960323334,
      "177": 0.20521050691604614,
      "68": 0.19991618394851685,
      "37": 0.1932646781206131,
      "49": 0.1924721747636795,
      "21": 0.18869346380233765,
      "228": 0.18764112889766693,
      "9": 0.1747497022151947,
      "67": 0.16910997033119202,
      "350": 0.16301439702510834,
      "46": 0.15967866778373718,
      "14": 0.15110230445861816,
      "2": 0.1507750302553177,
      "77": 0.1494074910879135,
      "64": 0.14672613143920898,
      "193": 0.14099009335041046,
      "200": 0.13911117613315582,
      "29": 0.133794367313385,
      "79": 0.13349130749702454,
      "261": 0.1327994018793106,
      "239": 0.13148050010204315,
      "101": 0.12322352081537247,
      "179": 0.12045417726039886,
      "243": 0.12023238837718964,
      "104": 0.11735278367996216,
      "114": 0.11728838831186295,
      "72": 0.11567530035972595,
      "194": 0.11346425116062164,
      "126": 0.11162889748811722,
      "38": 0.10649485141038895,
      "341": 0.10362819582223892,
      "5": 0.10260312259197235,
      "191": 0.10086949169635773,
      "131": 0.10062013566493988,
      "27": 0.10021936148405075,
      "85": 0.09719329327344894,
      "76": 0.09671102464199066,
      "180": 0.0923985168337822,
      "30": 0.09003586322069168,
      "35": 0.08902698755264282,
      "86": 0.08825228363275528,
      "102": 0.08738179504871368,
      "396": 0.08685968071222305,
      "355": 0.08603250980377197,
      "249": 0.08340895920991898,
      "116": 0.08210941404104233,
      "151": 0.0806485041975975,
      "61": 0.07937058806419373,
      "288": 0.07737591117620468,
      "186": 0.07678040117025375,
      "139": 0.0766635611653328,
      "130": 0.07530320435762405,
      "82": 0.07500260323286057,
      "204": 0.0742250457406044,
      "147": 0.0727420374751091,
      "441": 0.07246043533086777,
      "269": 0.07179846614599228,
      "122": 0.06918729841709137,
      "144": 0.06766313314437866,
      "33": 0.06747309863567352,
      "28": 0.06637466698884964,
      "282": 0.06610473245382309,
      "466": 0.06574515253305435,
      "422": 0.0642067939043045,
      "97": 0.0637703463435173,
      "69": 0.0635221004486084,
      "253": 0.06292397528886795,
      "36": 0.06139783188700676,
      "212": 0.06099100410938263,
      "234": 0.060795191675424576,
      "18": 0.06044916436076164,
      "1": 0.0604192316532135,
      "286": 0.060239434242248535,
      "276": 0.06004708632826805,
      "356": 0.05765151232481003,
      "100": 0.057039160281419754,
      "297": 0.056834422051906586,
      "96": 0.05656188353896141,
      "454": 0.05597817525267601,
      "221": 0.05530937761068344,
      "361": 0.05521675944328308,
      "154": 0.054895639419555664,
      "136": 0.05399729311466217,
      "164": 0.05360225588083267,
      "142": 0.052740052342414856,
      "132": 0.052551593631505966,
      "75": 0.05209662765264511,
      "92": 0.051745735108852386,
      "256": 0.051708560436964035,
      "257": 0.05033358559012413,
      "535": 0.0501839742064476,
      "382": 0.04924115538597107,
      "211": 0.04898109287023544
    }
  },
  "safety": {
    "trial_1_safety": 0.35637834668159485,
    "trial_2_safety": 0.35637834668159485
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4812021255493164
  }
}